EVNIN LUKE
Director
- Shares
- 107,429
- Price
- $0.31
- Value
- $33,303
HOWL
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$7,486,905
17 distinct insiders
Highlighted alerts
20
80 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
HOWL overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 dated March 26, 2026. The shares were sold as follows: 3,832 by MPM Asset Management LLC ("AM LLC"), 24,197 by MPM BioVentures 2014, L.P. ("BV 2014"), 1,614 by MPM BIoVentures 2014(B), L.P. ("BV 2014(B)"), 833 by MPM Asset Management Investors BV2014 LLC ("AM BV2014") and 5,294 by MPM Oncology Innovations Fund, L.P. ("MPM OIF"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3128 to $0.3388 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. MPM Oncology Innovations Fund GP LLC ("MPM OIF GP") is the general partner of MPM OIF. Luke Evnin is a member of AM LLC, a Managing Director of BV LLC and a manager of MPM OIF GP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. The shares are held as follows: 11,509 by AM LLC, 72,676 by BV 2014, 4,845 by BV 2014(B), 2,499 by AM BV2014 and 15,900 by MPM OIF. The shares were sold as follows: 11,509 by AM LLC, 72,676 by BV 2014, 4,845 by BV 2014(B), 2,499 by AM BV2014 and 15,900 by MPM OIF. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.295 to $0.3342 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. No shares held by AM LLC, BV 2014, BV 2014(B), AM BV2014 and MPM OIF.
Reason: rule_10b5_1. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
EVNIN LUKE
Director
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
EVNIN LUKE
Director
RA CAPITAL MANAGEMENT, L.P.
10% owner
RA CAPITAL MANAGEMENT, L.P.
10% owner
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
Former 10% Owner
GADICKE ANSBERT
Former 10% Owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
Former 10% Owner
GADICKE ANSBERT
Former 10% Owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
Former 10% Owner
GADICKE ANSBERT
Former 10% Owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
10% owner
GADICKE ANSBERT
10% owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
10% owner
GADICKE ANSBERT
10% owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
10% owner
GADICKE ANSBERT
10% owner
EVNIN LUKE
Director
MPM BioVentures 2014, L.P.
10% owner
GADICKE ANSBERT
10% owner
EVNIN LUKE
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 07, 2026 | EVNIN LUKE Director | Sale | 107,429 | $0.31 | $33,303 | |
| Jul 06, 2026 | EVNIN LUKE Director | Sale | 35,770 | $0.32 | $11,446 | |
| Jun 29, 2026 | EVNIN LUKE Director | Sale | 157,084 | $0.30 | $47,125 | |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 27,695 | $0.35 | $9,693 | |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 389,216 | $0.35 | $136,226 | |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 9,939 | $0.37 | $3,677 | |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 139,686 | $0.37 | $51,684 | |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 8,554 | $0.39 | $3,336 | |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 120,216 | $0.39 | $46,884 | |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 11,322 | $0.40 | $4,529 | |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 159,119 | $0.40 | $63,648 | |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 17,437 | $0.38 | $6,626 | |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 245,066 | $0.38 | $93,125 | |
| Jun 10, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 3,051 | $0.37 | $1,129 | |
| Jun 10, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 42,872 | $0.37 | $15,863 | |
| Jun 09, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 24,565 | $0.37 | $9,089 | |
| Jun 09, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 345,235 | $0.37 | $127,737 | |
| Jun 09, 2026 | EVNIN LUKE Director | Sale | 76,928 | $0.37 | $28,463 | |
| Jun 08, 2026 | EVNIN LUKE Director | Sale | 60,547 | $0.40 | $24,219 | |
| Jun 05, 2026 | EVNIN LUKE Director | Sale | 24,946 | $0.40 | $9,978 | |
| Jun 04, 2026 | EVNIN LUKE Director | Sale | 20,072 | $0.44 | $8,832 | |
| Jun 03, 2026 | EVNIN LUKE Director | Sale | 29,749 | $0.42 | $12,495 | |
| Jun 02, 2026 | EVNIN LUKE Director | Sale | 29,595 | $0.45 | $13,318 | |
| Jun 01, 2026 | EVNIN LUKE Director | Sale | 80,459 | $0.47 | $37,816 | |
| May 29, 2026 | EVNIN LUKE Director | Sale | 32,556 | $0.45 | $14,650 | |
| May 28, 2026 | EVNIN LUKE Director | Sale | 27,698 | $0.46 | $12,741 | |
| May 27, 2026 | EVNIN LUKE Director | Sale | 80,852 | $0.48 | $38,809 | |
| May 26, 2026 | EVNIN LUKE Director | Sale | 67,950 | $0.47 | $31,937 | |
| May 22, 2026 | EVNIN LUKE Director | Sale | 87,425 | $0.45 | $39,341 | |
| May 21, 2026 | EVNIN LUKE Director | Sale | 36,387 | $0.42 | $15,283 | |
| May 20, 2026 | EVNIN LUKE Director | Sale | 85,895 | $0.43 | $36,935 | |
| May 19, 2026 | EVNIN LUKE Director | Sale | 62,970 | $0.45 | $28,337 | |
| May 18, 2026 | EVNIN LUKE Director | Sale | 22,184 | $0.50 | $11,092 | |
| May 13, 2026 | EVNIN LUKE Director | Sale | 44,679 | $0.54 | $24,127 | |
| May 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 6,719 | $0.64 | $4,300 | |
| May 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 94,432 | $0.64 | $60,436 | |
| May 12, 2026 | EVNIN LUKE Director | Sale | 67,885 | $0.64 | $43,446 | |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 5,812 | $0.67 | $3,894 | |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 81,678 | $0.67 | $54,724 | |
| May 11, 2026 | EVNIN LUKE Director | Sale | 33,948 | $0.67 | $22,745 | |
| May 08, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 25,012 | $0.71 | $17,759 | |
| May 08, 2026 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | 351,514 | $0.71 | $249,575 | |
| May 08, 2026 | EVNIN LUKE Director | Sale | 305,741 | $0.70 | $214,019 | |
| May 07, 2026 | EVNIN LUKE Director | Sale | 79,086 | $0.63 | $49,824 | |
| May 06, 2026 | EVNIN LUKE Director | Sale | 14,635 | $0.66 | $9,659 | |
| May 05, 2026 | EVNIN LUKE Director | Sale | 6,860 | $0.69 | $4,733 | |
| May 04, 2026 | EVNIN LUKE Director | Sale | 47,963 | $0.72 | $34,533 | |
| May 01, 2026 | EVNIN LUKE Director | Sale | 58,394 | $0.73 | $42,628 | |
| Apr 30, 2026 | EVNIN LUKE Director | Sale | 168,262 | $0.72 | $121,149 | |
| Apr 29, 2026 | EVNIN LUKE Director | Sale | 56,559 | $0.69 | $39,026 | |
| Apr 28, 2026 | EVNIN LUKE Director | Sale | 95,412 | $0.73 | $69,651 | |
| Apr 27, 2026 | EVNIN LUKE Director | Sale | 53,940 | $0.85 | $45,849 | |
| Jan 16, 2026 | EVNIN LUKE Director | Sale | 38,782 | $0.54 | $20,942 | |
| Jan 15, 2026 | EVNIN LUKE Director | Sale | 37,413 | $0.55 | $20,577 | |
| Jan 14, 2026 | EVNIN LUKE Director | Sale | 30,616 | $0.57 | $17,451 | |
| Jan 13, 2026 | EVNIN LUKE Director | Sale | 43,198 | $0.55 | $23,759 | |
| Jan 12, 2026 | EVNIN LUKE Director | Sale | 58,980 | $0.57 | $33,619 | |
| Jan 09, 2026 | EVNIN LUKE Director | Sale | 24,678 | $0.61 | $15,054 | |
| Jan 08, 2026 | EVNIN LUKE Director | Sale | 7,716 | $0.63 | $4,861 | |
| Jan 07, 2026 | EVNIN LUKE Director | Sale | 11,915 | $0.64 | $7,626 | |
| Jan 06, 2026 | EVNIN LUKE Director | Sale | 40,761 | $0.65 | $26,495 | |
| Jan 05, 2026 | EVNIN LUKE Director | Sale | 18,378 | $0.64 | $11,762 | |
| Jan 02, 2026 | EVNIN LUKE Director | Sale | 18,568 | $0.63 | $11,698 | |
| Dec 31, 2025 | EVNIN LUKE Director | Sale | 24,962 | $0.62 | $15,476 | |
| Dec 30, 2025 | EVNIN LUKE Director | Sale | 34,847 | $0.61 | $21,257 | |
| Dec 29, 2025 | EVNIN LUKE Director | Sale | 108,606 | $0.61 | $66,250 | |
| Dec 26, 2025 | EVNIN LUKE Director | Sale | 35,632 | $0.63 | $22,448 | |
| Dec 24, 2025 | EVNIN LUKE Director | Sale | 16,310 | $0.65 | $10,602 | |
| Dec 23, 2025 | EVNIN LUKE Director | Sale | 71,428 | $0.63 | $45,000 | |
| Dec 22, 2025 | EVNIN LUKE Director | Sale | 59,307 | $0.69 | $40,922 | |
| Dec 17, 2025 | EVNIN LUKE Director | Sale | 9,983 | $1.14 | $11,381 | |
| Dec 16, 2025 | EVNIN LUKE Director | Sale | 14,548 | $1.05 | $15,275 | |
| Dec 15, 2025 | EVNIN LUKE Director | Sale | 23,640 | $1.07 | $25,295 | |
| Dec 12, 2025 | EVNIN LUKE Director | Sale | 17,858 | $1.08 | $19,287 | |
| Dec 11, 2025 | EVNIN LUKE Director | Sale | 28,009 | $1.07 | $29,970 | |
| Dec 10, 2025 | EVNIN LUKE Director | Sale | 37,104 | $1.06 | $39,330 | |
| Dec 09, 2025 | EVNIN LUKE Director | Sale | 44,570 | $1.01 | $45,016 | |
| Dec 08, 2025 | EVNIN LUKE Director | Sale | 34,041 | $0.99 | $33,701 | |
| Dec 05, 2025 | EVNIN LUKE Director | Sale | 16,568 | $0.97 | $16,071 | |
| Dec 04, 2025 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale | 83,230 | $0.97 | $80,733 | |
| Dec 04, 2025 | GADICKE ANSBERT Former 10% Owner | Sale | 83,230 | $0.97 | $80,733 | |
| Dec 04, 2025 | EVNIN LUKE Director | Sale | 53,416 | $0.97 | $51,814 | |
| Dec 03, 2025 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale | 57,225 | $0.87 | $49,786 | |
| Dec 03, 2025 | GADICKE ANSBERT Former 10% Owner | Sale | 57,225 | $0.87 | $49,786 | |
| Dec 03, 2025 | EVNIN LUKE Director | Sale | 36,726 | $0.87 | $31,952 | |
| Dec 02, 2025 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale | 59,277 | $0.89 | $52,757 | |
| Dec 02, 2025 | GADICKE ANSBERT Former 10% Owner | Sale | 59,277 | $0.89 | $52,757 | |
| Dec 02, 2025 | EVNIN LUKE Director | Sale | 38,043 | $0.89 | $33,858 | |
| Dec 01, 2025 | MPM BioVentures 2014, L.P. 10% owner | Sale | 60,917 | $0.94 | $57,262 | |
| Dec 01, 2025 | GADICKE ANSBERT 10% owner | Sale | 60,917 | $0.94 | $57,262 | |
| Dec 01, 2025 | EVNIN LUKE Director | Sale | 39,096 | $0.94 | $36,750 | |
| Nov 28, 2025 | MPM BioVentures 2014, L.P. 10% owner | Sale | 20,277 | $0.99 | $20,074 | |
| Nov 28, 2025 | GADICKE ANSBERT 10% owner | Sale | 20,277 | $0.99 | $20,074 | |
| Nov 28, 2025 | EVNIN LUKE Director | Sale | 13,014 | $0.99 | $12,884 | |
| Nov 26, 2025 | MPM BioVentures 2014, L.P. 10% owner | Sale | 60,733 | $0.98 | $59,518 | |
| Nov 26, 2025 | GADICKE ANSBERT 10% owner | Sale | 60,733 | $0.98 | $59,518 | |
| Nov 26, 2025 | EVNIN LUKE Director | Sale | 38,978 | $0.98 | $38,198 | |
| Nov 25, 2025 | MPM BioVentures 2014, L.P. 10% owner | Sale | 42,533 | $0.92 | $39,130 | |
| Nov 25, 2025 | GADICKE ANSBERT 10% owner | Sale | 42,533 | $0.92 | $39,130 | |
| Nov 25, 2025 | EVNIN LUKE Director | Sale | 27,297 | $0.92 | $25,113 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.